This trial is active, not recruiting.

Conditions body dysmorphic disorder, bdd
Treatments cognitive behavior therapy, supportive therapy
Sponsor Karolinska Institutet
Start date November 2013
End date January 2016
Trial size 100 participants
Trial identifier NCT02010619, BDD RCT


To evaluate if Internet delivered cognitive behavior therapy is an efficacious treatment when compared to a control group consisting of supportive therapy.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking single blind (outcomes assessor)
Primary purpose treatment
cognitive behavior therapy
(Active Comparator)
supportive therapy

Primary Outcomes

Body Dysmorphic Disorder Modification of the Y-BOCS (BDD-YBOCS)
time frame: Change in BDD-YBOCS from baseline (week 0) to post-treatment (week 12)

Secondary Outcomes

The Montgomery Åsberg Depression Rating Scale - self report (MADRS-S)
time frame: Change in MADRS-S from baseline (week 0) to post-treatment (week 12)

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - outpatient - ≥ 18 years - primary diagnosis of BDD according to the DSM-5 - BDD-YBOCS ≥20 - regular access to a computer with Internet access and skills to use the web. Exclusion Criteria: - psychotropic medication changes within two months prior to the treatment, - completed CBT for BDD within the last 12 months, - other primary axis I diagnosis - current substance dependence - lifetime bipolar disorder or psychosis - suicidal ideation - Axis II diagnosis that could jeopardize treatment participation, - other current psychological treatment that could affect BDD symptoms - A serious medical illness that precludes participation in the study

Additional Information

Official title Internet Delivered Cognitive Behavior Therapy for Body Dysmorphic Disorder - a Randomized Controlled Trial
Trial information was received from ClinicalTrials.gov and was last updated in March 2015.
Information provided to ClinicalTrials.gov by Karolinska Institutet.